Abstract Lymph nodes (LNs) are highly confined environments with a cell-dense threedimensional meshwork, in which lymphocyte migration is regulated by intracellular contractile proteins. However, the molecular cues directing intranodal cell migration remain poorly characterized. Here we demonstrate that lysophosphatidic acid (LPA) produced by LN fibroblastic reticular cells (FRCs) acts locally to LPA 2 to induce T-cell motility. In vivo, either specific ablation of LPA-producing ectoenzyme autotaxin in FRCs or LPA 2 deficiency in T cells markedly decreased intranodal T cell motility, and FRC-derived LPA critically affected the LPA 2 -dependent T-cell motility. In vitro, LPA activated the small GTPase RhoA in T cells and limited T-cell adhesion to the underlying substrate via LPA 2 . The LPA-LPA 2 axis also enhanced T-cell migration through narrow pores in a three-dimensional environment, in a ROCK-myosin II-dependent manner. These results strongly suggest that FRC-derived LPA serves as a cell-extrinsic factor that optimizes T-cell movement through the densely packed LN reticular network.
Introduction
Blood-borne naïve lymphocytes migrate along the fibroblastic reticular cell (FRC) network in lymph nodes (LNs) (von Andrian and Mempel, 2003; Miyasaka and Tanaka, 2004; Girard et al., 2012) . B cells then migrate into LN follicles, whereas T cells remain in the paracortex and migrate continually along the FRC network (Bajénoff et al., 2006) . This intranodal migration provides critical opportunities for T cells to encounter cognate antigen-presenting dendritic cells. Two-photon microscopic analysis has shown that naïve T cells crawl along the FRC network in an apparently random pattern of motion, at an average velocity of 10-15 mm per minute (Miller et al., 2002; Okada and Cyster, 2007; Worbs et al., 2007) . FRCs promote intranodal T-cell motility by signaling naïve lymphocytes with CCL21/CCL19 via CCR7, thus activating the small GTPase Rac (Okada and Cyster, 2007; Worbs et al., 2007; Faroudi et al., 2010; Huang et al., 2007) , although CCR7 signaling only partially account for the interstitial T cell motility (Okada and Cyster, 2007; Huang et al., 2007) .
LPA is a bioactive lysophospholipid produced both extracellularly and intracellularly. Extracellularly produced LPA is involved in such diverse biological functions as vascular remodeling and cell growth, survival, and migration (Choi et al., 2010; Yanagida et al., 2013) . Intracellularly produced LPA is an intermediate in the synthesis of triglycerides and glycerophospholipids, and thought to act as a 'housekeeper' inside the cell (Mills and Moolenaar, 2003) . Extracellular LPA is predominantly produced by autotaxin (ATX, also referred to as ENPP2 [ectonucleotide pyrophosphatase/phosphodiesterase family member 2]), an ectoenzyme that was originally identified as a tumor-cell motilityenhancing factor (Stracke et al., 1992) . ATX is a lysophospholipase D that produces LPA by hydrolyzing lysophosphatidylcholine (LPC) (Okudaira et al., 2010; Moolenaar and Perrakis, 2011) . We and others have reported that ATX is strongly expressed in HEV endothelial cells (ECs), and that ATX regulates lymphocyte migration into the LN parenchyma (Kanda et al., 2008; Nakasaki et al., 2008; Umemoto et al., 2011) . We also demonstrated that LPA enhances lymphocyte detachment from ECs and promotes lymphocyte transmigration across the HEV basal lamina, at least in part by acting on HEV ECs (Bai et al., 2013) . LPA also acts on naïve T cells to induce chemokinesis and cell polarization (Kanda et al., 2008; Katakai et al., 2014; Zhang et al., 2012) and transmigration (Zhang et al., 2012) .While a study using pharmacological inhibitors revealed that ATX/LPA promotes intranodal lymphocyte motility in an ex vivo LN explant model (Katakai et al., 2014) , the physiological significance of the ATX/LPA axis in interstitial lymphocyte migration remains unknown.
To date, six LPA receptors (LPA 1 -LPA 6 ) have been identified. LPA receptors couple to multiple G proteins, including G i , G 12/13 , G q , and G s , and upon ligand binding, these G proteins activate diverse intracellular signaling components including Rho and Rac. Although LPA 2 has recently been reported to play a role in intranodal T-cell migration (Knowlden et al., 2014) , it remains unclear how LPA 2 -mediated signaling affects interstitial T-cell motility and whether LPA is the prime activating ligand.
eLife digest Small organs called lymph nodes are found throughout the body and help to filter out harmful particles and cells. Lymph nodes are packed with different types of immune cells, such as the T-cells that play a number of roles in detecting and destroying bacteria, viruses and other disease-causing microbes. Within the lymph node, T-cells crawl along a meshwork made up of cells called fibroblastic reticular cells. The T-cells appear to move in random patterns, but the signals that drive this movement remain ill-defined. Now, Takeda et al. reveal that a lipid called lysophosphatidic acid (LPA), which is produced by the fibroblastic reticular cells, is responsible for regulating how T-cells move around inside the lymph nodes. T-cells are able to detect LPA via certain receptor proteins on their surface. Takeda et al. engineered mice that were either unable to produce a particular LPA receptor on their T-cells, or that produced less LPA than normal. The T-cells of these mice moved around less than T-cells in normal mice.
Further experiments revealed that LPA signaling also affects the signaling pathway that alters how well the T-cells stick to nearby surfaces. This suggests that LPA helps to optimize T-cell movement to allow the cells to navigate the small spaces found between the fibroblastic reticular cells. In the future, targeting the processes involved in LPA signaling could help to develop new treatments for disorders of the immune system.
Leukocyte migration in a confined environment is regulated at least partly by cell contraction (Lämmermann et al., 2008) . Jacobelli et al. (2010) reported that a contractile protein, myosin IIA, is required for T-cell amoeboid motility in confined environments such as LNs (Jacobelli et al., 2010) . Myosin IIA cross-links actin, thus limiting surface adhesion and allowing T cells to exert contractile force. Myosin IIA's activity is regulated by RhoA and Rho-associated protein kinase (ROCK) signaling. While the cell-extrinsic factor(s) that regulate myosin II's activity during T-cell migration in a confined environment have been poorly defined, a recent study using zebrafish germ progenitor cells showed that LPA induces cell polarization in a ROCK-myosin II-dependent manner, which enables rapid cell migration in a confined environment (Ruprecht et al., 2015) .
In this study, by using mice conditionally deficient for the LPA-generating enzyme ATX in FRCs and those deficient in LPA 2 , we demonstrated that bioactive LPA species are produced by FRCs in an ATX-dependent manner and that LPA acts locally on LPA 2 on T cells. This LPA 2 -mediated signaling activates the RhoA-ROCK-myosin II pathway and promotes confinement-optimized interstitial Tcell migration. The FRC-derived LPA thus serves as a cell-extrinsic factor that optimizes T-cell movement through the densely packed LN reticular network, to fine-tune T-cell trafficking. Although CCR7 ligands are reported to stimulate intranodal T-cell motility (Okada and Cyster, 2007; Worbs et al., 2007; Huang et al., 2007) , they are not sufficient to account for effective T-cell migration in LNs. Given that ATX, which generates the motogenic lysophospholipid, LPA, is expressed in HEV ECs to modulate lymphocyte motility (Nakasaki et al., 2008; Bai et al., 2013) , we speculated that ATX and its product LPA are also expressed in other stromal cell subsets in the LN parenchyma and may control intranodal lymphocyte migration. Indeed, a recent paper showed that ATX is expressed in CCL21 + CD31 -stromal cells in LNs (Katakai et al., 2014) . We therefore subdivided the CD45 -LN stromal cells into four stromal subsets ( Figure 1A ). As shown in Figure 1B , Enpp2/Autotaxin was readily detected in GP38 + CD31 -FRCs as well as GP38 -CD31 + blood endothelial cells (ECs), with negligible expression in lymphatic ECs and double-negative cells. Electron microscopic analysis confirmed that ATX was expressed in the FRCs surrounding collagen fiber bundles ( Figure 1C) . Interestingly, analyses using Ccl19-Cre x R26-EYFP mice, which constitutively express yellow fluorescent protein (YFP) in FRCs (Chai et al., 2013) , revealed that Enpp2 was selectively expressed in LN FRCs but not splenic FRCs ( Figure 1D ). This Enpp2 expression was apparently dependent on LTbR signaling, because blocking LTbR signaling significantly reduced expression of Enpp2, Cxcl13, and Ccl19, but not Icam1, in FRCs ( Figure 1E ). This blockade also downregulated transcription of HEV marker genes such as Glycam1 and Ccl21 in BECs ( Figure 1E ), consistent with a previous report (Browning et al., 2005) . These results confirm that similarly to HEV ECs, FRCs constitutively express the LPA-generating enzyme ATX, which is maintained at least in part by LTbR signaling.
Multiple LPA species are produced in the LN parenchyma by FRCs
To verify that LPA is generated in situ by FRC-derived ATX, we crossed Enpp2 fl/fl mice and Ccl19-Cre mice to generate Ccl19-Cre Enpp2 fl/fl mice that lacked ATX expression specifically in the FRCs.
As expected, in the Ccl19-Cre Enpp2 fl/fl mice, Enpp2 was completely lost in the FRCs but not in the BECs, whereas Ccl21 and GP38 expression was comparable between these strains ( We then compared LPA production in the LN of these mice using imaging mass spectrometry (IMS). To this end, we first injected fluorescein-conjugated dextran, which labels lymphatics and the medulla, into the footpad, and LPA (18:0), LPA (18:1), LPA (18:2), and LPA (20:4) were then visualized in LN sections. As shown in Figure 2B , signals corresponding to LPA (18:0) were widely distributed in the LN. The signals were comparable in intensity and frequency in Enpp2 fl/fl and Ccl19-Cre Enpp2 fl/fl mice; this LPA species appears to be produced mainly within the cell (Aoki, J; unpublished observation) independently of ATX (Yukiura et al., 2011 , Nishimasu, et al., 2011 . In sharp contrast, signals corresponding to LPA (18:1), LPA (18:2), and LPA (20:4), the major species produced extracellularly by ATX (Yukiura et al., 2011) , were predominantly observed in the paracortex both close to and at a distance from HEVs, but only marginally in the medulla. These signals were substantially decreased in the cortex of Ccl19-Cre Enpp2 fl/fl as compared with Enpp2 fl/fl mice ( Figure 2B ).
To verify that the cortical LPA signals associated with non-HEV structures were derived from FRCs, we next mapped the LPA signals relative to HEVs in Enpp2 fl/fl mice and Ccl19-Cre Enpp2 fl/fl mice by measuring the distance between individual signals and the nearest HEV. As shown in Figure 2C , the frequency of LPA 
FRC-derived LPA promotes intranodal T-cell migration
To understand the role of FRC-derived LPA in regulating intranodal T-cell migration, we next examined the CD4 + T-cell interstitial migration in LNs by intravital two-photon microscopy. To this end, CD4 + T cells from WT mice expressing a transgene encoding enhanced GFP (eGFP) were injected intravenously into Enpp2 fl/fl and Ccl19-Cre Enpp2 fl/fl mice, and the intranodal T-cell migration in popliteal LNs (PLNs) was imaged 15-25 hr later (Video 1). As shown in Figure 3A , B, CD4 + T-cell movement and displacement from the original location in the PLN was substantially restricted in Ccl19-Cre Enpp2 fl/fl compared with Enpp2 fl/fl mice. The median T-cell velocity was also lower in Ccl19-Cre Differences between groups were evaluated by Student's t-test. *P < 0.05, **P < 0.005, ***P < 0.0005. Bars, 100 mm. DOI: 10.7554/eLife.10561.004
The following figure supplement is available for figure 2: mean displacement and the motility coefficient, which represents the volume in which an average cell scans per unit time (Sumen et al., 2004) , also indicated that T-cell motility was impaired in the LN parenchyma of Ccl19-Cre Enpp2 fl/fl mice ( Figure 3D ,E), whereas the directionality of the intranodal T-cell movement was comparable in these mouse groups (Figure 3-figure supplement 2), supporting the hypothesis that FRC-derived LPA is required for efficient intranodal T-cell migration.
Adoptively transferred Lpar2-deficient T cells are retained in LNs
To understand how LPA regulates intranodal Tcell migration, we analyzed the LPA-receptor expression in lymphocytes. As shown in Figure 4A , CD4 + T cells, CD8 + T cells, and B cells expressed different levels of Lpar2, Lpar5, and Lpar6, encoding LPA 2 , LPA 5 and LPA 6 respectively, with B cells expressing relatively high levels of Lpar2 compared to T cells. We next examined whether LPA-receptor deficiency in lymphocytes causes abnormal migration into LNs, as seen in myosin IIA-deficient T cells (Jacobelli et al., 2010) . Splenocytes from eGFPexpressing mice and from LPA receptor-deficient mice were biotinylated, mixed in equivalent numbers, and injected intravenously into WT recipients, and lymphocytes that migrated into the LNs and spleen were counted 1.5 hr later. As shown in Figure 4B , Lpar5 -/-and Lpar6 -/-lymphocytes migrated into the LN and spleen at levels comparable to WT lymphocytes. In contrast, there were more Lpar2 -/-than WT lymphocytes in the LNs but not the spleen ( Figure 4B ,C). Among the migrating cells, this increase was evident for CD4 + T cells and CD8 + T cells but not B cells ( Figure 4D ). A similar increase was also observed when purified CD4 + T cells were used ( Figure 4G ). These results suggest two possibilities for the role of LPA 2 : one is that LPA 2 negatively regulates the entry of T cells into LNs across HEVs, and the other is that LPA 2 promotes intranodal T-cell motility and hence their egress from the LNs. To test these hypotheses, we co-injected differentially labeled WT and Lpar2 -/-T cells and examined their intranodal localization after 90 min by whole-mount LN analysis. Among the donor T cells in the LN parenchyma, Lpar2 -/-and WT T cells localized in the vicinity of HEVs (within 50 mm distance) at comparable levels ( Figure 4E and F), indicating that LPA 2 plays a minor role in T cell entry into LNs across HEVs. By contrast, Lpar2 -/-T cells localized more frequently in the area distant (more than 50 mm away) from HEVs compared with WT T cells ( Figure 4E and F), consistent with the hypothesis that LPA promotes intranodal T cell migration via LPA 2 , and hence, Lpar2-deficient T cells were retained in the LN parenchyma. To directly assess the involvement of the LPA 2 signaling in T-cell egress from LNs, we blocked the T cell entry by injecting anti-L-selectin antibody MEL-14 intravenously (T = 0 hr), and measured the number of WT and Lpar2 -/-CD4 + T cells residing in the LNs 23 hr after the injection. As shown in Figure 4G , the blockade of T cell entry (T = 23 hr) resulted in reduction of the cellularity in LNs and increased the ratio of Lpar2 -/-T cells to WT cells compared to that before the injection. These results indicate that retention of Lpar2-deficient T cells was seen even after blockade of lymphocyte ingress to LNs and are compatible with the hypothesis that Lpar2-deficiency leads to T cell retention in the LN parenchyma without affecting lymphocyte migration into LNs.
LPA 2 -mediated signaling regulates intranodal T-cell migration
To verify that LPA 2 -mediated signaling is required for intranodal T-cell motility, we next compared the intranodal migration of Lpar2-deficient and WT T cells. We adoptively transferred CD4 + T cells from Lpar2 -/-mice and WT mice and used intravital two-photon microscopy to compare the behavior of these cells in the PLN of the recipient mice. Preliminary experiments indicated that the lymphocyte labeling used for in vivo cell tracking did not affect cell motility under the experimental . These results indicate that intranodal T-cell motility is regulated via LPA 2 on T cells and that the LPA 2 -mediated T-cell motility requires FRC-derived LPA. Because LFA-1 regulates high-speed intranodal T cell migration (Katakai et al., 2013; Woolf et al., 2007) , we examined integrin dependency in the LPA 2 -mediated intranodal T-cell migration by transferring the WT and Lpar2 -/-T cells and monitoring the cell migration before and after injecting anti-LFA-1 antibody (M17/4). As shown in Figure 5H -J and Figure 5 -figure supplement 3C-E, the blockade of the interaction between LFA-1 and ICAM-1 significantly attenuated WT T cell motility as reported previously (Katakai et al., 2013; Woolf et al., 2007) . Of note, even in the absence of the LFA-1/ICAM-1 interaction, Lpar2 deficiency reduced T-cell motility, and the extent of reduction in T-cell velocity (19.9 ± 5.5%) and motility coefficient (43.5 ± 16.8%) was comparable to that observed in the presence of the integrin interaction (15.8 ± 4.4% and 43.0 ± 13.6% reduction in velocity and motility coefficient, respectively) ( Figure 5H -J and Figure 5 -figure supplement 3C-E). These results support the hypothesis that LPA/LPA 2 regulates T-cell motility at least partly in an integrin-independent manner.
LPA enhances T-cell migration across narrow pores in an LPA 2 /Rhodependent manner
LPA is reported to promote T-cell migration in a two-dimensional (2D) environment by inducing chemokinesis (Katakai et al., 2014; Zhang et al., 2012; Knowlden et al., 2014) . We therefore investigated the motility of WT and Lpar2-deficient CD4 + T cells in a 2D environment by time-lapse microscopy. Untreated or LPA-pretreated CD4 + T cells were applied to one side of an EZ-Taxiscan chamber coated with ICAM-1, and the migration of cells toward CCL21 placed on the other side of the chamber was monitored in real time. As shown in Figure 6A ,B, WT T cells efficiently migrated toward CCL21 in response to LPA in a time-dependent manner. Compared to untreated WT T cells, LPA-sensitized WT T cells had a higher velocity and a smaller mean turning angle ( Figure 6C,D) . In contrast, LPA treatment did not enhance the migration of Lpar2 -/-T cells toward CCL21.
We next examined whether LPA also regulates T-cell migration via LPA 2 in a three-dimensional (3D) environment, in which leukocyte migration largely depends on actomyosin contraction (Lämmermann and Germain, 2014) . Transwell analyses have shown that lymphocyte migration across a filter with a 3-mm pore diameter depends on ROCK/myosin II signaling, while migration across a 5-mm pore does not (Soriano et al., 2011) . Since LPA induces chemokinesis (Kanda et al., 2008; Katakai et al., 2014) , we added LPA to lymphocytes placed in the upper chamber of a Transwell apparatus with a 3-mm pore diameter filter and counted the cells that migrated to the lower well. As shown in Figure 7A , LPA sensitization enhanced the migration of CD4 + T cells, and this enhancement was strongly inhibited by the ROCK inhibitor Y27632 (Figure 7A ), or the myosin II ATPase inhibitor blebbistatin ( Figure 7B ), but not by pertussis toxin (PTX), which inhibits Gai signaling ( Figure 7A) . At 1 mM, LPA prominently induced chemokinesis in WT CD4 + T cells, consistent with previous reports (Kanda et al., 2008; Katakai et al., 2014 ) ( Figure 7C ), but this effect was not observed in Lpar2 -/-CD4 + T cells ( Figure 7C ). As shown in Figure 7D and E, LPA induced RhoA activation in WT but not Lpar2
-/-CD4 + T cells. Reminiscent of the findings of Soriano et al for ROCK/myosin II signaling (Soriano et al., 2011) , LPA noticeably enhanced the CCL21-dependent migration of T cells across a 3-mm-but not 5-mm-pore diameter filter ( Figure 7F) , and that Lpar2 deficiency abolished the LPA-induced enhancement ( Figure 7G) .
The myosin II signaling allows T cells to make selective contacts with the adhesive substrates, enabling rapid movement (Jacobelli et al., 2010) . We thus measured cell surface adhesion area in WT and Lpar2 -/-T cells by total internal reflection fluorescence (TIRF) microscopy (Jacobelli et al., 2010) . As shown in Figure 8A ,B, and D, LPA limited T-cell adhesion area on the fibronectin-or ICAM-1-coated substrate in WT T cells, which was inhibited by treatment of cells with blebbistatin, but this effect was not observed in Lpar2 -/-T cells, suggesting that Lpar2 -/-T cells over-adhere to substrate coated with or without LFA-1 ligand. Consistently, the LPA/LPA 2 signaling induced T-cell elongation in a myosin II-dependent manner, allowing swift cell movement ( Figure 8A , C, E). We finally analyzed LPA's effect on lymphocyte migration in a more complex confined 3D environment using 3D collagen gel ( Figure 9A ). T cells were placed in type I collagen gel, with LPA placed on one side of the gel and CCL21 plus LPA (5 mM) on the other. WT T cells efficiently migrated toward CCL21 in the presence of LPA, with increased displacement ( Figure 9B ) and velocity ( Figure 9C ) compared with cells stimulated with CCL21 alone, whereas the directionality of T cell movement in the gel was comparable in the presence or absence of LPA (Figure 9 -figure supplement 1). The LPA's effect was abrogated by treatment of the cells with Y27632 or blebbistatin ( Figure 9D) . In Lpar2 -/-T cells, CCL21 did not enhance motility in the presence of LPA ( Figure 9B , C). These results collectively indicate that in confined 3D environments, the LPA-LPA 2 axis regulates T-cell motility in a manner dependent on Rho, ROCK, and actomyosin. Taken together, these results strongly suggest that the LPA 2 signaling modulates T cell motility in the confined environments at least partly in an integrin-independent manner and may also act on cell adhesion to prevent over-adhesion to the substrates. LPA produced by FRCs is essential for this LPA 2 -dependent T-cell motility in densely packed LN parenchyma.
Discussion
LN tissue is densely packed with several types of cells, including lymphocytes, dendritic cells, and mesenchymal stromal cells. Lymphocyte migration in such confined environments is influenced by a delicate balance between actin polymerization/cell adhesion and actomyosin contraction/cell deadhesion. In this study, we demonstrated that LPA is generated ATX-dependently by FRCs in the LN parenchyma, and that the LPA/LPA 2 -mediated signal activates Rho/myosin II in T cells. LPA 2 Video 2. Lpar2 deficiency attenuated the intranodal Tcell motility. Intravital two-photon microscopy of the intranodal migration of eGFP-expressing CD4 + T cells signaling enhances T-cell migration in confined 3D collagen matrices and promotes interstitial T-cell migration in LNs in a manner dependent on FRC-derived LPA. These results strongly suggest that the LPA-LPA 2 axis critically regulates the confinement-optimized T-cell motility in LNs. We previously reported that ATX and LPA are produced by HEV ECs and pericytes (Bai et al., 2013) . In the present study, we found that ATX is also generated by LN FRCs, in agreement with another recent study (Katakai et al., 2014) , and that multiple LPA species are present in the LN parenchyma; in particular, we showed that LPA (18:1), LPA (18:2), and LPA (20:4) are produced in the paracortex in a manner dependent on FRC-derived ATX. The enzyme ATX has substrate specificity for LPCs with different acyl-chain lengths and saturations. Recombinant mouse ATX prefers LPC species with relatively short, unsaturated acyl chains, and produces LPA (18:2), LPA (16:0), LPA (20:4), and LPA (18:1) but not LPA (18:0) (Yukiura et al., 2011) . Consistent with this observation, crystal structural analysis revealed that ATX accommodates LPA (18:1) and LPA (18:3) but not LPA (18:0) in a stable conformation in its hydrophobic pocket, accounting for ATX's preferences for the number of unsaturated bonds of LPC (18:0 < 18:1 < 18:3) (Nishimasu et al., 2011) . While LPA (18:0) signals were detected in the LN parenchyma, they were ubiquitously found in other tissues independently of ATX expression; these signals are likely to represent intracellularly produced LPA, an CMFDA-labeled T cells were incubated on a fibronectin-(A-C) or ICAM-1-(D, E) coated slide glass, pretreated with or without blebbistatin (50 mM), and stimulated with LPA (1 mM). The adhesion area of CD4 + cells was assessed by TIRF microscopy (green) (A-B, D) . Aspect ratio (cell length/cell breadth) and circularity (4 x p x area/perimeter 2 ) (C, E) were assessed by bright-field images. Bars: 5 mm. Data are pooled from two independent experiments. Differences between groups were evaluated by one-way ANOVA. ***P < 0.0005. DOI: 10.7554/eLife.10561.018 Figure 9 . LPA/LPA 2 axis promotes T-cell motility in a confined 3D environment. (A) Illustration of the 3D migration assay. The cell suspension was mixed with collagen gel (1.6 mg/ml). CCL21 (5 mg/ml) was loaded into one side of the gel, and LPA (5 mM) was applied to both sides. The migration of eGFP-expressing CD4 + T cells or their Lpar2 -/-counterparts was recorded for 120 min by time-lapse microscopy. (B) Manual tracking of T cell motility.
(C) T cell velocity. See also the directionality of T cell movement in Figure 9 -figure supplement 1. (D) Involvement of myosin II/ ROCK in LPA-induced T cell motility. After eGFP-expressing CD4 + T cells and WT counterparts were treated with vehicle and indicated inhibitors, respectively, they were mixed with the collagen gel and monitored for cell migration. Data are representative of two independent experiments (B, C) and pooled from two independent experiments (D). Differences between groups were evaluated by Student's t-test (C) or one-way ANOVA (D). *P < 0.05, **P < 0.005, ***P < 0.0005. DOI: 10.7554/eLife.10561.019
The following figure supplement is available for figure 9:
Figure supplement 1. Effect of LPA on the directionality of T-cell movement in 3D collagen gel. DOI: 10.7554/eLife.10561.020
intermediate in the synthesis of triglycerides and glycerophospholipids inside the cell (Mills and Moolenaar, 2003) , which is relatively inert in activating LPA receptors (Bandoh et al., 2000) . Taken together, our findings indicate that multiple biologically relevant LPA species (18:1, 18:2, 20:4) are produced by FRCs, which may in turn act locally on LPA receptors expressed by adjacent lymphocytes. Lymphocyte morphology and migration modes adjust according to the microenvironmental context. T-cell motility on a 2D surface requires integrin-mediated adhesive forces and detachment from the integrin substrates, whereas the 3D T-cell motility in LNs only partially requires LFA-1-mediated interactions (Woolf et al., 2007) . Jacobelli et al. (Jacobelli et al., 2010; Jacobelli et al., 2009) reported that lymphocytes are not restricted to adhesion-dependent motility in 3D environments, and that myosin IIA controls T-cell motility modes-including amoeboid motility, which is dependent on the degree of confinement of 3D environment, and prevents excessive adhesions on non-integrin substrates. In our in vitro model, LPA limited T-cell adhesion area on the fibronectin-and ICAM-1-coated substrate, and promoted chemokine-induced T-cell migration across 3-mm but not 5-mm filter pores and also in a confined collagen gel via LPA 2 signaling. This enhanced migration was inhibited by the ROCK inhibitor Y27632 or the myosin II ATPase inhibitor blebbistatin. In vivo, the LPA/LPA 2 axis promoted intranodal T-cell migration even in the absence of interaction between LFA-1 and its ligand. These findings indicate that LPA acts on LPA 2 to enhance T-cell motility in chemokine-rich, confined environments at least partly independently of integrin-mediated adhesion or de-adhesion, and this enhancement depends mainly on ROCK/myosin IIA activity.
The importance of LPA 2 in lymphocyte motility is suggested in recent findings by Knowlden et al (Knowlden et al., 2014) indicating that Lpar2 deficiency in lymphocytes is associated with inefficient lymphocyte movement within LNs, although it was not shown how LPA 2 -signaling affects lymphocyte migration and what kind of cells provide the ligand for LPA 2 . On the other hand, we showed that LPA activated the Rho GTPase in T cells via LPA 2 , promoting chemokine-induced T-cell migration across 3-mm-but not 5-mm-pore filters in vitro. We further demonstrated that FRC-derived LPA signaled T cells through LPA 2 to sustain optimal T-cell motility in the LN parenchyma. Thus, LPA appears to serve as a cell-extrinsic factor regulating myosin II activity in CD4 + T cells, and the LPA 2 / ROCK/myosin II signaling pathway is critical for T-cell migration in the confined LN parenchymal environment. In addition, we showed that transferred Lpar2 -/-T cells accumulated in LNs more abundantly than WT counterparts 1.5-2 hr after the cell transfer (Figure 4) , whereas Knowlden et al showed that Lpar2-deficiency did not affect T-cell trafficking to LNs significantly 42 hr after cell transfer (Knowlden et al., 2014) . It has been shown previously that intravenously injected CD4 + T cells swiftly migrate into LNs and a majority of them reside there for only about 12 hr (Mandl et al., 2012) before they enter the circulation. Therefore, at the time point used by Knowlden et al (Knowlden et al., 2014) , labeled T cells in LNs might have included those that have re-entered into LNs. We and others previously reported that LPA locally produced by HEV ECs regulates constitutive lymphocyte transmigration across HEVs (Bai et al., 2013; Zhang et al., 2012) . This raises the question of whether LPA produced in the HEV area also affects T-cell motility in the LN parenchyma. In this regard, we are currently investigating the effect of EC-specific ATX ablation on lymphocyte behaviors within LNs but do not yet have a definitive answer. Concerning the question of whether LPA produced in the LN parenchyma would affect T-cell extravasation from the HEVs, we found comparable lymphocyte migration across HEVs in Enpp2 fl/fl and Ccl19-Cre Enpp2 fl/fl mice (unpublished observation). Given that Ccl19-Cre mice express transgenes in FRCs and in the mesenchymal cells ensheathing HEV ECs, but not in HEV ECs (Chai et al., 2013) , and that biologically relevant LPA species were produced near HEVs at comparable levels in Ccl19-Cre Enpp2 fl/fl mice and Enpp2 fl/fl mice ( Figure 2B,C) , it appears that ATX produced outside HEVs plays a minor or dispensable role in the lymphocyte transmigration across HEVs. While B cells expressed high levels of Lpar2 ( Figure 4A ), adoptively transferred Lpar2-deficient B cells were not retained in the LN ( Figure 4D) . Since B cells, like T cells, showed chemokinesis in response to LPA in an LPA 2 -dependent manner (unpublished observation), B cells may possess functional downstream elements for LPA 2 -mediated signals. However, whether their intranodal motility depends on motogenic factor(s) other than LPA requires further investigation.
Naïve T cells continuously search for antigen-bearing dendritic cells in the FRC-rich paracortex, and their random migration creates critical opportunities to encounter cognate antigens. It is possible that LPA promotes immune responses by increasing the T cells' chances of encountering dendritic cells. Once activated by TCR stimulation, T cells reduce their migration speed and S1P 1 expression, and thus gain time to proliferate and differentiate into effector cells within the LN (Schwab and Cyster, 2007) . Interestingly, TCR activation is reported to downregulate LPA 2 expression (Knowlden et al., 2014; Huang et al., 2002) , which might reduce the velocity of the T cells and allow them to achieve proper activation.
Taken together, our work offers direct evidence that multiple biologically relevant LPA species produced by FRCs in an ATX-dependent manner act locally on LPA 2 on T cells. This LPA 2 -mediated signaling activates the RhoA-ROCK-myosin II pathway and promotes confinement-optimized interstitial T-cell migration in LNs at least partly in an integrin-independent manner. Thus, the LPA-LPA 2 axis is an attractive pharmacological target for novel strategies to control immune responses.
Materials and methods
Mice C57BL/6J mice were obtained from Japan SLC. Beta-actin-eGFP mice were a gift from Dr. Masaru Okabe (Research Institute of Microbial Diseases, Osaka University) (Okabe et al., 1997) . Lpar2 -/-mice and Enpp2-flox mice were provided by Dr. Jerold Chun (the Scripps Research Institute) (Contos et al., 2002) and Dr. Woulter H. Moolenaar (The Netherlands Cancer Institute) (van Meeteren et al., 2006) , respectively, to one of us (JA). The Ccl19-Cre mice were described previously (Chai et al., 2013) . The Lpar5 -/-and Lpar6 -/-mice will be described elsewhere. B6.129X1-Gt (ROSA)26Sor tm1Hjf (R26-YFP) mice and CD45.1 mice were purchased from the Jackson Laboratory (Bar Harbor, ME 
Reagents and antibodies
Anti-PNAd (MECA-79) mAb was purified using a size-exclusion column with size-exclusion resin (Toyopearl TSK HW55; Tosoh, Japan) from the ascites of mice inoculated with the hybridoma. Purified MECA-79 was labeled with the Alexa Fluor 488 Protein Labeling Kit (Thermo Fisher Scientific, Waltham, MA). APC anti-CD4, Pacific Blue anti-CD8, APC-Cy7 anti-B220, APC anti-gp38, and biotin anti-CD31 mAbs were purchased from Biolegend (San Diego, CA). Anti-L-selectin mAb (MEL-14) was generated from the hybridoma, and anti-integrin LFA-1 (aL) mAb (M17/4) was purchased from Bio X cell (Lebanon, NH). Streptavidin-BD Horizon V500 was obtained from BD Biosciences (San Jose, CA), and LPA (18:1) and blebbistatin were from Sigma-Aldrich (St. Louis, MO). Mouse CCL21 and mouse ICAM-1-Fc were from R&D Systems (Minneapolis, MN).
Stromal cell isolation
FRCs and BECs were isolated as described previously (Fletcher et al., 2011) . Cells were incubated with PE anti-CD45, APC anti-gp38, and biotin anti-CD31 mAbs, followed by streptavidin-BD Horizon V500. Stromal-cell populations were sorted by FACSAria (BD Biosciences).
Real-time RT-PCR
Total RNA was isolated using RNeasy (Qiagen, Germany), and single-strand cDNA was synthesized using M-MLV reverse transcriptase (Promega, Fitchburg, WI) with a random primer. PCR was performed using the Go Taq qPCR system (Promega) at 95˚C for 10 min followed by 40 cycles at 95˚C for 15 s and 60˚C for 1 min. The PCR primer pairs are described in Supplementary file 1.
Transmission electron microscopy ATX localization was examined by immuno-transmission electron microscopy as previously described (Bai et al., 2013) . Cryosections were incubated with a guinea pig-derived polyclonal antibody against mouse ATX.
Soluble LTbR-Fc treatment
The LTbR-Fc expression vector, in which LTbR's extracellular domain was fused to the Fc region of human IgG 1 , was a gift from Dr. Atsushi Togawa (Yoshida et al., 2002 ) (Fukuoka University Hospital). LTbR-Fc was expressed in 293T cells and purified by a HiTrap Protein A column (GE Healthcare, UK). To block LTbR signaling, LTbR-Fc or control human IgG Fc (100 mg each) was injected intraperitoneally into mice (8-12 weeks old) weekly for 4 weeks as described previously (Browning et al., 2005) .
Imaging mass spectrometry (IMS)
IMS was performed as previously described (Bai et al., 2013) , with minor modifications. Briefly, fluorescein-conjugated dextran (40 kDa) (Thermo Fisher Scientific) was injected into the foreleg footpads to visualize LN structures, and 10 min later, brachial LNs were collected and snap-frozen in liquid nitrogen. Cryosections (8-mm thick) were cut and transferred onto glass slides coated with Indium Tin Oxide (Resistance, 20 ohm; Matsunami, Japan). The sections were washed with 0.03% formate to remove endogenous salts and coated with matrix compound (10 mg/ml 9-aminoacridine dissolved in 70% ethanol 
Intravital two-photon microscopy
Intravital two-photon microscopy was performed as described previously . Briefly, CD4 + T cells were isolated by negative selection kits (Stemcell Tech, Canada or Miltenyi Biotec, Germany) from the LNs and spleen of eGFP-expressing and Lpar2 -/-mice. Lpar2 -/-CD4 + T cells were labeled with 5 mM CMTMR (Thermo Fisher Scientific), mixed with an equivalent number of WT CD4 + T cells, and injected into recipient mice (5 x 10 6 cells/mouse); 15-25 hr later, the mice were anesthetized using isoflurane admixed with O 2 . The animals were placed on a custom-built preparation stage, the right hind leg was immobilized, and microdissection tweezers were used to expose the PLNs without jeopardizing the blood vessels and afferent lymphatic vessels. Sterile PBS at 37˚C was applied to the stage to submerge the LNs, and the temperature was maintained at 37˚C using a heating pad with a feedback probe. Two-photon laser-scanning microscopy was performed with an upright Leica TCS SP5 equipped with a 20x water immersion objective (HCX APO, N.A. 1.0; Leica, Germany) and a MaiTai Ti:sapphire-pulsed laser (Spectra-Physics, Santa Clara, CA) set at 880 nm for two-photon excitation. To generate time-lapse series, stacks of more than 30 x-y sections spaced at 2-3 mm were acquired every 20-30 s in resonance mode. For evaluating integrin-dependency in LPA-induced T-cell motility, 300 mg of anti-LFA-1 antibody was intravenously injected, and 1 hr later, cell migration was monitored again. Imaris software (Bitplane, UK) was used to track cells in 3D and measure the cells' velocity and x, y, z coordinates. Mean displacement plots were calculated from the x, y, z coordinates using Excel (Microsoft, Redmond, WA) as described previously (Sumen et al., 2004) . The motility coefficient (M) was calculated from the mean displacement plot as M = D 2 /6t, in which D is displacement and t is time, using 10-min tracks. The directionality of cells' motion was calculated by dividing cells' net displacement by the total path length, using over 10-min tracks (Sumen et al., 2004) .
Lymphocyte migration assay by flow cytometry
Lymphocyte migration was assayed by flow cytometry as previously described (Bai et al., 2009) . Splenocytes from eGFP-expressing mice and LPA receptor-deficient mice were mixed in equal numbers and incubated with Sulfo-NHS-LC-biotin reagent (80 mg/ml) (Thermo Fisher Scientific) for 30 min (Nolte et al., 2004) . The biotin-labeled cells were injected intravenously into recipient mice (2 x 10 7 cells/mouse), and the LNs and spleen were harvested 1.5 hr later. The cell suspension was incubated with APC anti-CD4, Pacific Blue anti-CD8, APC-Cy7 anti-B220 mAbs, and streptavidin-PE. The frequencies of T and B cells in GFP + and GFP -populations of biotinylated cells were analyzed by flow cytometry (FACSCanto, BD Biosciences).
Lymphocyte migration assay with whole-mount microscopy Lymphocyte migration was assayed by whole-mount microscopy as described previously (Kanemitsu et al., 2005) . Briefly, WT and Lpar2 -/-CD4 + T cells (L-selectin + CD44 -naïve T cells in CD4 + T cells of WT and Lpar2 -/-mice were 79.7 ± 10.7% and 78.7 ± 9.1%, respectively) were isolated by negative immunomagnetic cell sorting (Miltenyi Biotec) and labeled with 5 mM DiD and 5 mM CMTMR (Thermo Fisher Scientific), respectively. The cells were mixed in equal numbers (1 x 10 7 cells) and injected intravenously into WT mice; after 1.5 hr, MECA-79 mAb was injected to label the luminal HEV surface, and inguinal LNs were isolated. The LNs were fixed with 4% paraformaldehyde in phosphate buffer and incubated with sucrose (30%). Immunofluorescence signals were observed with a confocal laser-scanning microscope (FV1000-D, Olympus, Japan). The distance between T cells and the nearest HEV was measured using Imaris software.
T cell retention assay
T cell retention was assessed as described before with minor modifications (Pham et al., 2008) . CD45.1 + WT and CD45.2 + Lpar2 -/-CD4 + T cells were isolated by negative sorting, mixed in equal numbers (1 x 10 7 cells), and labeled with 2 mM of CFSE (Thermo Fisher Scientific). The cells were injected intravenously into recipient WT mice; 2 hr later, the LNs and spleen were collected from half of the recipient mice, and 100 mg of anti-L-selectin antibody (MEL-14) was intraperitoneally injected into the rest of the recipient mice; 23 hr later, tissues were harvested from the antibodytreated mice. The frequency of donor-derived T cells was measured by flow cytometry.
Time-lapse 2D chemotaxis assay
An EZ-Taxiscan chamber (Effector Cell Institute, Japan) was used for time-lapse chemotaxis assays as described previously (Bai et al., 2009) . Negatively sorted CD4 + T cells were incubated in serumfree medium for 30 min at 37˚C. Cells were suspended in LPA (1 mM)-containing or control buffer (0.1% BSA/RPMI1640) and loaded into microchamber wells (4-mm deep), each holding a cover glass precoated with ICAM-1 (5 mg/ml), and 100 ng of CCL21 was applied to the contra-wells. Phase-contrast images of migrating cells were acquired at 1-min intervals for 1 hr at 37˚C. Cells that migrated toward the contra-wells were counted from the images, and 30 migrating cells were tracked using the ImageJ (NIH) manual tracking plug-in. ImageJ software was also used to measure the cells' velocity and x, y coordinates. Turning angles were calculated with Excel using the cells' x, y coordinates.
Transwell migration assay
LN cells were incubated in serum-free medium (0.1% BSA/RPMI1640) for 30 min at 37˚C. The cells (1 x 10 6 cells) were added in the presence or absence of LPA to the upper chamber of a Transwell apparatus (pore size, 3 or 5 mm; Corning, Corning, NY) and allowed to migrate for 2 hr at 37˚C. In some experiments, CCL21 (200 ng/ml) was added to the lower chamber. Migrated cells were counted by flow cytometry using 6.0-mm Fluoscribe microspheres (Polysciences, Warrington, PA).
RhoA-GTP pull-down assay FCS and fatty acid-free BSA were incubated with activated charcoal (Wako, Japan) to remove all lipid fractions. The spleen and LNs were collected, and a single-cell suspension was prepared in RPMI1640 containing 1% FCS. T cells were negatively sorted and starved in serum-free medium (0.1% BSA/RPMI1640) for 2 hr at 37˚C. Next, cells (1 x 10 7 ) were stimulated with 1 mM LPA at 37˚C 
